Assessment of Current Medical Management Approaches for Thyroid Nodules and Cancer in a Tertiary Care Setting

Asif Iqbal; Zahid  Mehboob; Ihtisham Haq

doi:10.62497/IRABCS.2024.78

Authors

Asif Iqbal Department of Microbiology Hazara University Mansehra KPK Pakistan Author https://orcid.org/0000-0001-7150-5346
Zahid Mehboob Institute of Molecular Biology and Biotechnology (IMBB) The University of Lahore 53700, Pakistan Author https://orcid.org/0000-0003-3785-8580
Ihtisham ul Haq Department: medical lab technology, Kohat university of science and technology, kohat, Pakistan Author https://orcid.org/0009-0000-0867-4577

DOI:

https://doi.org/10.62497/IRABCS.2024.78

Keywords:

thyroid nodules, thyroid cancer, levothyroxine, therapy, papillary carcinoma, thyroid complications, diagnosis

Abstract

Background: Cancer and thyroid nodules are serious worldwide health issues that need accurate diagnosis and treatment to stop their development. Even with improvements in diagnostic techniques and therapeutic approaches, there are still unanswered questions about the best medical care.

Objective: This study aimed to assess current medical treatment approaches for thyroid nodules and cancer, identifying areas for improvement and suggesting interventions to enhance patient outcomes.

Methodology: The study's objective was to evaluate medical treatment modalities for thyroid nodules and cancer among hospitalized patients from January to December 2023. 290 patients in all were chosen depending on how often they visited the hospital. Standardized forms were used in the data gathering process to extract clinical and demographic information from databases and records. Descriptive statistics and multivariate logistic regression were used in the statistical analysis using SPSS 25.0.

Results: The research examined 290 individuals with cancer and thyroid nodules, most of them were female (62.07%) and varied in age. Sixty-five percent of the samples showed benign nodules, with papillary thyroid carcinoma being the most common kind (39.31%). The most common treatment (45.86%) was levothyroxine therapy, which was successful in 75.19% of patients. Levothyroxine was shown to be substantially related with favorable outcomes (odds ratio: 2.50) by multivariate logistic regression. Hypothyroidism (9.77%-18.18%) and hyperthyroidism (4.51%-6.06%) were among the side effects.

Conclusion: The study emphasizes the crucial role of levothyroxine in achieving positive outcomes and underscores the importance of effectively managing treatment-related complications to improve patient care.

Downloads

Download data is not yet available.

Author Biographies

Zahid Mehboob, Institute of Molecular Biology and Biotechnology (IMBB) The University of Lahore 53700, Pakistan

Institute of Molecular Biology and Biotechnology (IMBB) The University of Lahore 53700, Pakistan 03459552831
Ihtisham ul Haq, Department: medical lab technology, Kohat university of science and technology, kohat, Pakistan

Department: medical lab technology, Kohat university of science and technology, kohat, Pakistan

References

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. Journal of cancer epidemiology. 2013 Oct;2013. https://doi.org/10.1155/2013/965212.

Deng Y, Li H, Wang M, Li N, Tian T, Wu Y, Xu P, Yang S, Zhai Z, Zhou L, Hao Q. Global burden of thyroid cancer from 1990 to 2017. JAMA network Open. 2020 Jun 1;3(6):e208759-. https://doi.org/10.1001/jamanetworkopen.2020.8759.

Riaz SH, Assir MZ, Jawa A, Akram J. Thyroid Nodule. Thyroid Disorders: Basic Science and Clinical Practice. 2016:239-52. https://doi.org/10.1007/978-3-319-25871-3_13.

Polyzos SA, Kita M, Avramidis A. Thyroid nodules-stepwise diagnosis and management. HORMONES-ATHENS-. 2007 Apr 1;6(2):101. http://www.hormones.gr/pdf/Thyroid%20nodules_Stepwise%20diagnosis.pdf.

Kuo JH, McManus C, Graves CE, Madani A, Khokhar MT, Huang B, Lee JA. Updates in the management of thyroid nodules. Current Problems in Surgery. 2019 Mar 1;56(3):103-27. https://doi.org/10.1067/j.cpsurg.2018.12.003.

Rusinek D, Chmielik E, Krajewska J, Jarzab M, Oczko-Wojciechowska M, Czarniecka A, Jarzab B. Current advances in thyroid cancer management. Are we ready for the epidemic rise of diagnoses?. International journal of molecular sciences. 2017 Aug 22;18(8):1817. https://doi.org/10.3390/ijms18081817.

HaugenBryan R, AlexanderErik K, BibleKeith C, DohertyGerard M, MandelSusan J, NikiforovYuri E, RandolphGregory W, SawkaAnna M, SchuffKathryn G, ShermanSteven I, Ann S. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan 12. https://doi.org/10.1089/thy.2015.0020.

Omur O, Baran Y. An update on molecular biology of thyroid cancers. Critical reviews in oncology/hematology. 2014 Jun 1;90(3):233-52. https://doi.org/10.1016/j.critrevonc.2013.12.007.

Hassoun D, Malard O, Barbarot S, Magnan A, Colas L. Type 2 immunity‐driven diseases: Towards a multidisciplinary approach. Clinical & Experimental Allergy. 2021 Dec;51(12):1538-52. https://doi.org/10.1111/cea.14029.

Nguyen QT, Lee EJ, Huang MG, Park YI, Khullar A, Plodkowski RA. Diagnosis and treatment of patients with thyroid cancer. American health & drug benefits. 2015 Feb;8(1):30. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415174/.

Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, Paciaroni A, Puxeddu E, Torlontano M, Tumino S, Attard M, Lamartina L. The natural history of benign thyroid nodules. Jama. 2015 Mar 3;313(9):926-35. https://doi.org/10.1001/jama.2015.0956.

Hussain T, Nguyen QT. Molecular imaging for cancer diagnosis and surgery. Advanced drug delivery reviews. 2014 Feb 1;66:90-100. https://doi.org/10.1016/j.addr.2013.09.007.

Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, Breuer CK, Dinauer CA, Udelsman R. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocrine reviews. 2011 Dec 1;32(6):798-826. https://doi.org/10.1210/er.2011-0011.

Schmidbauer B, Menhart K, Hellwig D, Grosse J. Differentiated thyroid cancer—treatment: state of the art. International journal of molecular sciences. 2017 Jun 17;18(6):1292. https://doi.org/10.3390/ijms18061292.

Croce L, Ruggeri RM, Cappelli C, Virili C, Coperchini F, Laganà M, Costa P, Dal Molin M, Chytiris S, Magri F, Chiovato L. Cardiovascular and metabolic comorbidities in patients with thyroid nodules: the impact of incidental diagnosis. Journal of Endocrinological Investigation. 2024 Apr;47(4):827-32. https://doi.org/10.1007/s40618-023-02191-4.

Galliano GE, Frishberg DP. Pathology and classification of thyroid tumors. Thyroid cancer. 2012:1-33. https://doi.org/10.1007/978-1-4614-0875-8_1.

Lawal O, Agbakwuru A, Olayinka OS, Adelusola K. Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment. European Journal of Surgical Oncology (EJSO). 2001 Mar 1;27(2):157-61. https://doi.org/10.1053/ejso.2000.1085.

Paschou SΑ, Vryonidou A, Goulis DG. Thyroid nodules: Α guide to assessment, treatment and follow-up. Maturitas. 2017 Feb 1;96:1-9. https://doi.org/10.1016/j.maturitas.2016.11.002.

Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. The Journal of Clinical Endocrinology & Metabolism. 2020 Sep;105(9):2869-83. https://doi.org/10.1210/clinem/dgaa322.

Kim C, Lee JH, Choi YJ, Kim WB, Sung TY, Baek JH. Complications encountered in ultrasonography-guided radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers. European radiology. 2017 Aug;27:3128-37. https://doi.org/10.1007/s00330-016-4690-y.

Sanchez Barrueco A, González Galán F, Alcalá Rueda I, Santillán Coello JM, Barrio Dorado MP, Villacampa Aubá JM, Escanciano Escanciano M, Llanos Jimenez L, Mahillo Fernández I, Cenjor Español C. Incidence and risk factors for radioactive iodine-induced sialadenitis. Acta oto-laryngologica. 2020 Nov 1;140(11):959-62. https://doi.org/10.1080/00016489.2020.1802507